These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18838735)

  • 1. Did prescription bias affect outcomes in a study of the relative effectiveness of osteoporosis drugs?
    Beri A; Khattri S
    Ann Intern Med; 2008 Oct; 149(7):514; author reply 514. PubMed ID: 18838735
    [No Abstract]   [Full Text] [Related]  

  • 2. Postmenopausal Osteoporosis.
    Michaëlsson K; Aspenberg P
    N Engl J Med; 2016 May; 374(21):2095. PubMed ID: 27223158
    [No Abstract]   [Full Text] [Related]  

  • 3. Postmenopausal Osteoporosis.
    Cheung AM; Papaioannou A; Morin S;
    N Engl J Med; 2016 May; 374(21):2096. PubMed ID: 27223160
    [No Abstract]   [Full Text] [Related]  

  • 4. Postmenopausal Osteoporosis.
    Ott SM
    N Engl J Med; 2016 May; 374(21):2095-6. PubMed ID: 27223159
    [No Abstract]   [Full Text] [Related]  

  • 5. Postmenopausal Osteoporosis.
    Black DM; Rosen CJ
    N Engl J Med; 2016 May; 374(21):2096-7. PubMed ID: 27223157
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessing the relative efficacy of different agents based on the outcomes from meta-analyses.
    Boonen S; Vanderschueren D; Haentjens P
    Int J Clin Pract; 2008 Jan; 62(1):164-5; author reply 165-6. PubMed ID: 18173819
    [No Abstract]   [Full Text] [Related]  

  • 7. Drugs for postmenopausal osteoporosis.
    Treat Guidel Med Lett; 2011 Nov; 9(111):67-74. PubMed ID: 22033166
    [No Abstract]   [Full Text] [Related]  

  • 8. Ten vs five years of bisphosphonate treatment for postmenopausal osteoporosis: enough of a good thing.
    Colón-Emeric CS
    JAMA; 2006 Dec; 296(24):2968-9. PubMed ID: 17190899
    [No Abstract]   [Full Text] [Related]  

  • 9. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.
    Perreault S; Dragomir A; Desgagné A; Blais L; Rossignol M; Blouin J; Moride Y; Ste-Marie LG; Fernandès JC
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):685-95. PubMed ID: 15645517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Osteoporosis.
    Cotts KG; Cifu AS
    JAMA; 2018 Mar; 319(10):1040-1041. PubMed ID: 29536084
    [No Abstract]   [Full Text] [Related]  

  • 11. Postmenopausal osteoporosis: another approach to management.
    Cole R
    J Fam Pract; 2010 Jun; 59(6):E1-7. PubMed ID: 20544058
    [No Abstract]   [Full Text] [Related]  

  • 12. Denosumab, osteoporosis, and prevention of fractures.
    Blackwood J
    N Engl J Med; 2009 Nov; 361(22):2189; author reply 2190-1. PubMed ID: 19950411
    [No Abstract]   [Full Text] [Related]  

  • 13. [Does ibandronate (Bonviva) have an impact on non-vertebral fractures?].
    Kastelan D; Vlak T
    Reumatizam; 2007; 54(2):87-8. PubMed ID: 18351153
    [No Abstract]   [Full Text] [Related]  

  • 14. Teriparatide for glucocorticoid-induced osteoporosis.
    Diez-Perez A; Sole E
    J Rheumatol; 2012 Mar; 39(3):461-2. PubMed ID: 22383352
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effectiveness of anti-resorption therapies of postmenopausal osteoporosis].
    Stĕpán J
    Vnitr Lek; 2007 Mar; 53(3):293-9. PubMed ID: 17503641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Denosumab (prolia) for postmenopausal osteoporosis.
    Med Lett Drugs Ther; 2010 Oct; 52(1349):81-2. PubMed ID: 21045756
    [No Abstract]   [Full Text] [Related]  

  • 17. Study shows that a new type of osteoporosis drug reduces fracture risk.
    Harv Womens Health Watch; 2009 Oct; 17(2):6-7. PubMed ID: 19998553
    [No Abstract]   [Full Text] [Related]  

  • 18. Denosumab, osteoporosis, and prevention of fractures.
    Blythe SL
    N Engl J Med; 2009 Nov; 361(22):2189-90; author reply 2190-1. PubMed ID: 19950410
    [No Abstract]   [Full Text] [Related]  

  • 19. Osteoporosis treatment options expand.
    Mayo Clin Health Lett; 2010 Nov; 28(11):4. PubMed ID: 21158019
    [No Abstract]   [Full Text] [Related]  

  • 20. [Which treatment for osteoporosis in women with contraindication to HRT?].
    Trémollieres F
    Rev Prat; 2010 Oct; 60(8):1133-6. PubMed ID: 21197752
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.